Publicación:
Sporotrichosis in Peru: Description of an area of hyperendemicity

dc.contributor.authorPappas, Peter G.
dc.contributor.authorTellez, Ildefonso
dc.contributor.authorDeep, Alexandria E.
dc.contributor.authorNolasco, Delia
dc.contributor.authorHolgado, Walter
dc.contributor.authorBustamante, Beatriz
dc.date.accessioned2026-05-01T06:25:55Z
dc.date.issued2000
dc.description.abstractSporotrichosis is a sporadic and rare mycotic infection in most of the developed world. In many parts of the developing world, sporotrichosis is much more commonly recognized, but epidemiological data are generally lacking from these regions. We report epidemiological, clinical, and treatment data from 238 cases of culture-proven sporotrichosis occurring in a relatively remote area of the south central highlands of Peru that were retrospectively collected during 1995-1997. Most cases (60%) occurred in children aged ≤14 years, and the most commonly affected anatomic site was the face. Disease was clinically confined to the skin and subcutaneous tissue in all patients. The incidence of sporotrichosis in this region ranged from 48 to 60 cases per 100,000 persons and was highest among children aged 7-14 years, approaching 1 case per 1000 persons. Sporotrichosis is a significant mycosis in the rural highlands of Peru, with an incidence exceeding those of other invasive mycoses in individuals without human immunodeficiency virus infection.en_US
dc.description.sponsorshipReceived 12 April 1999; revised 26 August 1999; electronically published 22 December 1999. This work was presented at the 36th annual meeting of the Infectious Diseases Society of America held on 12–15 November 1998 in Denver. The protocol of this study was approved by the InstitutionalReviewBoard of the University of Alabama at Birmingham. The assertions expressed in this article are the opinions of the authors and do not necessarily reflect the views or official policy of the US Department of Health and Human Services. The use of trade names, commercial products, or organizations does not imply endorsement by the US government. Financial support: This work was supported in part by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (contract NO1-AI-65296). Reprints or correspondence: Dr. Peter G. Pappas, University of Alabama at Birmingham, 1900 University Boulevard, 229 Tinsley Harrison Tower, Birmingham, AL 35294-0006 (ppappas@uabid.dom.uab.edu).es_PE
dc.identifier.doihttps://doi.org/10.1086/313607
dc.identifier.scopus2-s2.0-0033984943
dc.identifier.urihttps://hdl.handle.net/20.500.12866/19418
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.ispartofurn:issn:1058-4838
dc.relation.ispartofseriesClinical Infectious Diseases
dc.relation.issn1058-4838
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectmycosesen_US
dc.subjectchilden_US
dc.subjectperuen_US
dc.subjectsporotrichosisen_US
dc.titleSporotrichosis in Peru: Description of an area of hyperendemicityen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.type.localArtículo de revista
dc.type.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
dspace.entity.typePublication

Archivos